Dewanjee, S. et al. systematically assessed abnormal glucose metabolism associated with Ab and phosphorylated tau accumulation in AD brains, and they suggested the emerging role of altered glucose metabolism in contributing to the impact of insulin signaling and mitochondrial dysfunction in defective cerebral glucose utilization in AD [172]. Here, MAPT is linked to Alzheimer disease.